As of 2026-03-31, the Fair Value of Catalyst Pharmaceuticals Inc (CPRX) is 43.88 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 23.78 USD, the upside of Catalyst Pharmaceuticals Inc is 84.51%.
With the market price of 23.78 USD and our fair value calculation, Catalyst Pharmaceuticals Inc (CPRX) is a good investment. Investing in CPRX stocks now will result in a potential gain of 84.51%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 39.50 | 83.10 | 71.41 | 163.89 | 214.33 | 114.45 |
| YoY growth | -47.33% | 110.38% | -14.07% | 129.50% | 30.78% | 41.85% |
| Market Cap (mil) | 2,904.01 |
| P/E | 13.55x |
| Forward P/E | 12.95x |
| EPS | 1.76 |
| Avg earnings growth rate | 41.85% |
| TTM earnings | 214.33 |